Magazine: A choppy history of racial bias in oximetry
Business & Regulation
ArchiMed acquires neurodiagnostic devices provider Natus Medical
Natus shareholders received $33.50 in cash for each share of company common stock.
FDA identifies Avanos Medical’s Cortrak* 2 EAS recall as Class I
Medtronic concludes Intersect ENT acquisition
Cepheid secures FDA EUA for rapid Covid-19 diagnostic test
BD reports 2.1% increase in Q1 2022 revenues
Quidel’s quarterly revenues more than double to $1bn in Q1 2022
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
